Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SHR-1210”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Testing effectiveness (Phase 2)Ended earlyNCT03711279
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Jiangsu HengRui Medicine Co., Ltd. 99
Testing effectiveness (Phase 2)UnknownNCT02942329
What this trial is testing

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

Who this might be right for
Gastric CancerHepatocellular Carcinoma
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 60
Early research (Phase 1)Study completedNCT02721589
What this trial is testing

Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects

Who this might be right for
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 126
Testing effectiveness (Phase 2)UnknownNCT04239443
What this trial is testing

Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Who this might be right for
Advanced Non Small Cell Lung CancerUterine CancerSoft Tissue Sarcoma
Hunan Cancer Hospital 120
Testing effectiveness (Phase 2)UnknownNCT03986515
What this trial is testing

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Who this might be right for
Mucosal MelanomaAdvanced CancerApatinib+1 more
Henan Cancer Hospital 40
Large-scale testing (Phase 3)Study completedNCT03134872
What this trial is testing

SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+6 more
Jiangsu HengRui Medicine Co., Ltd. 419
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295317
What this trial is testing

PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 65
Testing effectiveness (Phase 2)Study completedNCT03755440
What this trial is testing

PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients.

Who this might be right for
Gastric Cancer Stage IVEBV
Sun Yat-sen University 6
Testing effectiveness (Phase 2)UnknownNCT03912857
What this trial is testing

Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)UnknownNCT04035876
What this trial is testing

Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant

Who this might be right for
Hepatocellular CarcinomaLiver Transplant
Zhejiang University 120
Large-scale testing (Phase 3)Study completedNCT03691090
What this trial is testing

Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 596
Testing effectiveness (Phase 2)UnknownNCT04974944
What this trial is testing

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Who this might be right for
Stage IVB Cervical CancerRecurrent Cervical CancerPersistent Cervical Cancer
Sun Yat-sen University 172
Testing effectiveness (Phase 2)UnknownNCT04108013
What this trial is testing

SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC

Who this might be right for
Lung Cancer Stage IIPD-1 AntibodyNon-small Cell Lung Cancer
Xuanwu Hospital, Beijing 38
Early research (Phase 1)UnknownNCT04665362
What this trial is testing

IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

Who this might be right for
Advanced/Metastatic Hepatocellular Carcinoma
Liang Peng 10
Testing effectiveness (Phase 2)Study completedNCT03394287
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Testing effectiveness (Phase 2)Ended earlyNCT03645876
What this trial is testing

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 12
Not applicableWithdrawnNCT04420130
What this trial is testing

A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）

Who this might be right for
Pancreatic CancerLiver Metastasis
Yanqiao Zhang
Testing effectiveness (Phase 2)UnknownNCT04204577
What this trial is testing

The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Chinese PLA General Hospital 90
Testing effectiveness (Phase 2)UnknownNCT04239170
What this trial is testing

Camrelizumab(SHR-1210) Combined With GEMOX in Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Peking University 84
Testing effectiveness (Phase 2)Study completedNCT03083041
What this trial is testing

SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu HengRui Medicine Co., Ltd. 210
Load More Results